United States · FDA National Drug Code directory
Sertraline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-757_5079a5d2-af51-4bac-aaad-75653da2aa97
- Product NDC
- 23155-757
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sertraline
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230223
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (23155-757-03) · 23155-757-03
- 500 TABLET, FILM COATED in 1 BOTTLE (23155-757-05) · 23155-757-05
- 90 TABLET, FILM COATED in 1 BOTTLE (23155-757-09) · 23155-757-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →